PATENT CLAIM ANALYSIS

Application Number: 15962982
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "256000"]

Abstract:
The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

Claim (Index 20):
The method of  claim 17 , wherein the (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-citrate is in crystalline form and the crystalline form is characterized by a powder x-ray diffraction pattern comprising at least one of the following peaks: 2\u03b8 11.02 \u00b1 0.1 20.01 \u00b1 0.1 22.06 \u00b1 0.1 24.66 \u00b1 0.1 32.13 \u00b1 0.1 33.35 \u00b1 0.1 34.61 \u00b1 0.1 35.96 \u00b1 0.1 38.65 \u00b1 0.1 \u200940.23 \u00b1 0.1.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 91.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13129898', '14074147', '15354832', '15539147', '15622544']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7474762188312037
- 35 USC 102 Novelty (BERT): 0.6175526608309674
- Combined Prediction Score: 0.7344838630311802
- Mean Citation Score: 410.296236
- Max Citation Score: 578.8974599999998
- Similarity Product: 509.27014201385

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test